Avantika Chenna is a Nephrology physician affiliated with Adventist HealthCare. OpenAlex indexes 31 publications with 471 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
550 S Landmark Ave
Bloomington, IN 474033239
Telephone
812-676-4660Provider last certified this registry record 1 Feb 2023.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20241 payment
- Otsuka America Pharmaceutical, Inc.Program year20221 payment
- Fresenius USA Marketing, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
72.7%Loop diuretic21.4%Torsemide57%Furosemide44%Part D≥48 patientsBeta blocker12.2%Carvedilol85%Metoprolol Succinate15%Part D<11 patients+ 10 more classes in this area
Metabolism & gastrointestinal
17.2%Vitamin D3 Analog9.3%Calcitriol100%Part D≥38 patientsPotassium supplement2.8%Potassium Chloride100%Part D≥12 patients+ 3 more classes in this area
Anti-infectives
3.2%First-generation cephalosporins3.2%Cephalexin100%Part D≥37 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- COVID-19 Pandemic Causing Acute Kidney Injury and Impact on Patients With Chronic Kidney Disease and Renal Transplantation
Journal of Clinical Medicine Research
2020 - COVID-19 and Renal Failure: Challenges in the Delivery of Renal Replacement Therapy
Journal of Clinical Medicine Research
2020 - Prognostic Value of Elevated Cardiac Troponin I in Hospitalized Covid-19 Patients
The American Journal of Cardiology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Dibianco, MD
Adventist HealthCare
Homam Ibrahim, MD
Adventist HealthCare
Bahri Bilir, MD
Adventist HealthCare
Daniel Boken, MD
Adventist HealthCare
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”